GHA
CPIX icon

GW Henssler & Associates’s Cumberland Pharmaceuticals CPIX Stock Holding History

GW Henssler & Associates’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-115,904
Closed -$693K – 173
2014
Q4 		$693K Sell
115,904
-100,000
-46% -$513K 0.08% 107
2014
Q3 		$1.07M Hold
215,904
– – 0.13% 94
2014
Q2 		$972K Hold
215,904
– – 0.12% 96
2014
Q1 		$972K Buy
215,904
+8,000
+4% +$38.1K 0.11% 100
2013
Q4 		$1.06M Buy
+207,904
New +$1.01M 0.12% 98

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

GW Henssler & Associates's CPIX Position: Q1 2015 in Review

GW Henssler & Associates sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2015, closing a stake of 115,904 shares — an estimated $693K sold.

GW Henssler & Associates first reported a position in CPIX in Q4 2013 and held it in 5 quarters. The position peaked at $1.07M in Q3 2014. 46 funds tracked by Wall St. Rank hold CPIX as of Q1 2015.

  • GW Henssler & Associates reported no remaining Cumberland Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • GW Henssler & Associates sold 115,904 Cumberland Pharmaceuticals shares in Q1 2015, an estimated $693K.
  • GW Henssler & Associates first reported a position in Cumberland Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • GW Henssler & Associates's Cumberland Pharmaceuticals position peaked at $1.07M in Q3 2014.
  • 46 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2015.

Based on GW Henssler & Associates's 13F filing for Q1 2015, filed 11 May 2015.